Quality Level
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CCTGACGGACCCCAGTAAACTGGACTCGGGGAAGGAGCTGCACATCAATCTCATTCCCAGCAAACAGGACCGAACCCTGACCATTGTGGATACCGGGATTGGAATGACCAAGGCCGACTTGATCAATAACCTTGGCACCATTGCCAAGTCGGGCACCAAAGCCTTCATGGAGGCTTTGCAGGCTGGTGCAGATATCTCTATGATTGGCCAGTTTGGTGTTGGTTTTTACTCTGCCTATTTGGTTGCTGAGAAAGTGACTGTCATCACGAAGCATAACGACGATGAGCAGTATGCCTGGGAGTCCTCAGCTGGGGGATCCTTCACAGTGAGGACTGACACAGGTGAACCAATGGGTCGTGGAACAAAGGTTATCTTGCATCTGAAAGAAGACCAAACAGAGTATTTGGAGGA
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... HSP90AA1(15519), Hsp90aa1(15519)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Robert O'Brien et al.
The Journal of biological chemistry, 290(31), 19287-19306 (2015-05-31)
The cascade of events that lead to cognitive decline, motor deficits, and psychiatric symptoms in patients with Huntington disease (HD) is triggered by a polyglutamine expansion in the N-terminal region of the huntingtin (HTT) protein. A significant mechanism in HD
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU203071-20UG | 04061831392210 |
| EMU203071-50UG | 04061828722181 |